Download PDF
Int J Angiol 2019; 28(03): 153-160
DOI: 10.1055/s-0039-1678691
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Importance of Flaxseed and its Components in the Management of Hypertension

Kailash Prasad
1   Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
22 February 2019 (online)

    Permissions and Reprints

Abstract

This review paper describes the effects of flaxseed and its components (flax oil, secoisolariciresinol diglucoside [SDG], flax lignan complex [FLC], and flaxseed protein hydrolysate [FPH]) on blood pressure (BP) in Sprague Dawley rats (SDR), spontaneously hypertensive rats (SHR), and humans. Flaxseed, flax oil, and FLC had variable effects on BP in humans, while SDG and FPH significantly reduced the BP in SDR and SHR. The effect of SDG was dose-dependent and long lasting. The lowering of BP is mediated through inhibition of soluble epoxide by α-linolenic acid in flax oil, stimulation of guanylate cyclase and inhibition of angiotensin converting enzyme (ACE) by SDG, and inhibition of renin and ACE activity by FPH. Flaxseed, flax oil, and FLC have variable effects on BP (none, slight, and significant). They are effective in lowering BP in individuals with hypertension and metabolic syndrome but ineffective in healthy individuals' ineffectiveness of flaxseed and its compounds in lowering BP may be due to their low doses, long interval of dosing, short duration of consumption, and patient status. In conclusion, the data at present suggest that flaxseed, flax oil, and FLC cannot serve as therapeutic agents for the treatment of hypertension. However, they can be used as an adjunct in the treatment of hypertension. A clinical trial should be conducted of these agents with higher doses which would be given twice daily for long duration. Pure SDG and FPS may serve as therapeutic agents for the treatment of hypertension but they have not been tried in humans.

Keywords

flaxseed - flax oil - secoisolariciresinol diglucoside (SDG) - flax lignan complex - flaxseed protein hydrolysate - blood pressure - hypertension - inhibition of soluble epoxide hydrolase by α-linolenic acid - inhibition of renin - ACE activity by SDG and protein hydrolysate - stimulation of guanylate cyclase by SDG
 

  • References

  • 1 The 7th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Available at: https://www.nhlbi.nih.gov/files/docs/guidelines/jnc7/full.pdf . Accessed January 23, 2019
    PubMed
  • 2 Whelton PK, Carey RM, Arnow WS. , et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71 (19) e127-e248
    CrossrefPubMedGoogle Scholar
  • 3 Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000; 85 (02) 251-255
    CrossrefPubMedGoogle Scholar
  • 4 Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360 (9343): 1347-1360
    CrossrefPubMedGoogle Scholar
  • 5 World Health Organization. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. Geneva: World Health Organization; 2013
    Google Scholar
  • 6 Stuglin C, Prasad K. Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther 2005; 10 (01) 23-27
    CrossrefPubMedGoogle Scholar
  • 7 Prasad K. Secoisolariciresinol diglucoside (SDG) isolated from flaxseed, an alternative to AGE-inhibitors in the treatment of hypertension. Int J Angiol 2013; 22 (04) 235-238
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Prasad K. Antihypertensive activity of secoisolariciresinol diglucoside (SDG) isolated from flaxseed: role of guanylate cyclase. Int J Angiol 2004; 13 (01) 7-14
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Rodriguez-Leyva D, Weighell W, Edel AL. , et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 2013; 62 (06) 1081-1089
    CrossrefPubMedGoogle Scholar
  • 10 Jackevicius CA, Cox JL, Carreon D. , et al; Canadian Cardiovascular Outcomes Research Team. Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ 2009; 181 (1,2): E19-E28
    CrossrefPubMedGoogle Scholar
  • 11 Oomah BD, Mazza G. Flaxseed proteins: a review. Food Chem 1993; 48 (02) 109-114
    CrossrefPubMedGoogle Scholar
  • 12 Hettiarachchy NS, Hareland GA, Ostenson A. Chemical composition of 11 flaxseed varieties grown in North Dakota. Proc Flax Institute 1990; 53: 36-39
    PubMedGoogle Scholar
  • 13 Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998; 136 (02) 367-375
    CrossrefPubMedGoogle Scholar
  • 14 Westcott ND, Paton DA. Complex containing lignan, phenolic and aliphatic substances from flax and process for preparing. US Patent 6,264,853. July 24, 2001
    PubMedGoogle Scholar
  • 15 Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999; 99 (10) 1355-1362
    CrossrefPubMedGoogle Scholar
  • 16 Kritchevsky D, Shirley AT, Klurfeld DM. Influence of flaxseed on serum and liver lipids in rats. J Nutr Biochem 1991; 2 (03) 133-134
    CrossrefPubMedGoogle Scholar
  • 17 Bernacchia R, Preti R, Vinci G. Chemical composition and health benefits of flaxseed. Austin J Nutr Food Sci 2014; 2 (08) 1045
    PubMedGoogle Scholar
  • 18 Epaminondas PS, Araújo KLGV, de Souza AL. , et al. Influence of toasting on the nutritious and thermal properties of flaxseed. J Therm Anal Calorim 2011; 106 (02) 551-555
    CrossrefPubMedGoogle Scholar
  • 19 Sargi SC, Silva BC, Santos HMC. , et al. Antioxidant capacity and chemical composition in seeds rich in omega-3: chia, flax, and perilla. Food Sci Technol (Campinas) 2013; 33 (03) 541-548
    CrossrefPubMedGoogle Scholar
  • 20 Hepburn FN, Exler J, Weihrauch JL. Provisional table on the content of n-3 fatty acids and other fat components in selected foods. J Am Diet Assoc 1986; 86 (06) 788-793
    PubMedGoogle Scholar
  • 21 Wescott ND, Muir AD. Process for extracting Lignans from flaxseed. U.S. Patent 5, 705,618. January 6, 1998
    PubMedGoogle Scholar
  • 22 Ingram AJ, Parbtani A, Clark WF. , et al. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. Am J Kidney Dis 1995; 25 (02) 320-329
    CrossrefPubMedGoogle Scholar
  • 23 Talom RT, Judd SA, McIntosh DD, McNeill JR. High flaxseed (linseed) diet restores endothelial function in the mesenteric arterial bed of spontaneously hypertensive rats. Life Sci 1999; 64 (16) 1415-1425
    CrossrefPubMedGoogle Scholar
  • 24 Dupasquier CMC, Weber A-M, Ander BP. , et al. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 2006; 291 (06) H2987-H2996
    CrossrefPubMedGoogle Scholar
  • 25 Dodin S, Lemay A, Jacques H, Légaré F, Forest JC, Mâsse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005; 90 (03) 1390-1397
    CrossrefPubMedGoogle Scholar
  • 26 Caligiuri SP, Aukema HM, Ravandi A, Guzman R, Dibrov E, Pierce GN. Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase. Hypertension 2014; 64 (01) 53-59
    CrossrefPubMedGoogle Scholar
  • 27 Wu H, Pan A, Yu Z. , et al. Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr 2010; 140 (11) 1937-1942
    CrossrefPubMedGoogle Scholar
  • 28 Khalesi S, Irwin C, Schubert M. Flaxseed consumption may reduce blood pressure: a systematic review and meta-analysis of controlled trials. J Nutr 2015; 145 (04) 758-765
    CrossrefPubMedGoogle Scholar
  • 29 Ursoniu S, Sahebkar A, Andrica F, Serban C, Banach M. ; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial. Clin Nutr 2016; 35 (03) 615-625
    CrossrefPubMedGoogle Scholar
  • 30 Hoffmann P, Förster W. Antihypertensive effect of dietary sunflowerseed oil and linseed oil in spontaneously hypertensive rats during a multigeneration feeding study. Prostaglandins Leukot Med 1986; 25 (01) 65-70
    CrossrefPubMedGoogle Scholar
  • 31 Ogawa A, Suzuki Y, Aoyama T, Takeuchi H. Dietary alpha-linolenic acid inhibits angiotensin-converting enzyme activity and mRNA expression levels in the aorta of spontaneously hypertensive rats. J Oleo Sci 2009; 58 (07) 355-360
    CrossrefPubMedGoogle Scholar
  • 32 Brändle M, al Makdessi S, Weber RK, Dietz K, Jacob R. Prolongation of life span in hypertensive rats by dietary interventions. Effects of garlic and linseed oil. Basic Res Cardiol 1997; 92 (04) 223-232
    CrossrefPubMedGoogle Scholar
  • 33 Dierberger B, Schäch M, Anadere I, Brändle M, Jacob R. Effect of a diet rich in linseed oil on complex viscosity and blood pressure in spontaneously hypertensive rats (SHR). Basic Res Cardiol 1991; 86 (06) 561-566
    CrossrefPubMedGoogle Scholar
  • 34 Sekine S, Sasanuki S, Aoyama T, Takeuchi H. Lowering systolic blood pressure and increases in vasodilator levels in SHR with oral α-linolenic acid administration. J Oleo Sci 2007; 56 (07) 341-345
    CrossrefPubMedGoogle Scholar
  • 35 Gryglewski RJ, Chłopicki S, Uracz W, Marcinkiewicz E. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med Sci Monit 2001; 7 (01) 1-16
    PubMedGoogle Scholar
  • 36 Djoussé L, Arnett DK, Pankow JS, Hopkins PN, Province MA, Ellison RC. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension 2005; 45 (03) 368-373
    CrossrefPubMedGoogle Scholar
  • 37 Tsukamoto I, Sugawara S. Low levels of linoleic acid and α-linolenic acid and high levels of arachidonic acid in plasma phospholipids are associated with hypertension. Biomed Rep 2018; 8 (01) 69-76
    PubMedGoogle Scholar
  • 38 Barceló-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr 2008; 88 (03) 801-809
    CrossrefPubMedGoogle Scholar
  • 39 Schwab US, Callaway JC, Erkkilä AT, Gynther J, Uusitupa MI, Järvinen T. Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors. Eur J Nutr 2006; 45 (08) 470-477
    CrossrefPubMedGoogle Scholar
  • 40 Takeuchi H, Sakurai C, Noda R. , et al. Antihypertensive effect and safety of dietary α-linolenic acid in subjects with high-normal blood pressure and mild hypertension. J Oleo Sci 2007; 56 (07) 347-360
    CrossrefPubMedGoogle Scholar
  • 41 Singer P, Jaeger W, Berger I. , et al. Effects of dietary oleic, linoleic and alpha-linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension. J Hum Hypertens 1990; 4 (03) 227-233
    PubMedGoogle Scholar
  • 42 Bemelmans WJ, Muskiet FA, Feskens EJ. , et al. Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease. Eur J Clin Nutr 2000; 54 (12) 865-871
    CrossrefPubMedGoogle Scholar
  • 43 Paschos GK, Magkos F, Panagiotakos DB, Votteas V, Zampelas A. Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 2007; 61 (10) 1201-1206
    CrossrefPubMedGoogle Scholar
  • 44 Dewell A, Marvasti FF, Harris WS, Tsao P, Gardner CD. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr 2011; 141 (12) 2166-2171
    CrossrefPubMedGoogle Scholar
  • 45 Nestel PJ, Pomeroy SE, Sasahara T. , et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 1997; 17 (06) 1163-1170
    CrossrefPubMedGoogle Scholar
  • 46 Chan Q, Stamler J, Griep LM, Daviglus ML, Horn LV, Elliott P. An update on nutrients and blood pressure. J Atheroscler Thromb 2016; 23 (03) 276-289
    CrossrefPubMedGoogle Scholar
  • 47 Berry EM, Hirsch J. Does dietary linolenic acid influence blood pressure?. Am J Clin Nutr 1986; 44 (03) 336-340
    CrossrefPubMedGoogle Scholar
  • 48 Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96 (02) 418-424
    CrossrefPubMedGoogle Scholar
  • 49 Barre DE, Mizier-Barre KA, Stelmach E. , et al. Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis-an invitation to further investigation into polypharmacy reduction. J Nutr Metab 2012; 2012: 585170
    CrossrefPubMedGoogle Scholar
  • 50 Viveky N, Thorpe L, Alcorn J, Hadjistavropoulos T, Whiting SJ. Safety evaluation of flax lignan supplementation in older adults residing in long-term care homes. J Nursing Home Res 2015; 1: 84-88
    PubMedGoogle Scholar
  • 51 Pan A, Sun J, Chen Y. , et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One 2007; 2 (11) e1148
    CrossrefPubMedGoogle Scholar
  • 52 Cornish SM, Chilibeck PD, Paus-Jennsen L. , et al. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 2009; 34 (02) 89-98
    CrossrefPubMedGoogle Scholar
  • 53 Hallund J, Tetens I, Bügel S. , et al. Daily consumption for six weeks of a lignan complex isolated from flaxseed does not affect endothelial function in healthy postmenopausal women. J Nutr 2006; 136 (09) 2314-2318
    CrossrefPubMedGoogle Scholar
  • 54 Johnsson P, Kamal-Eldin A, Lundgren LN, Aman P. HPLC method for analysis of secoisolariciresinol diglucoside in flaxseeds. J Agric Food Chem 2000; 48 (11) 5216-5219
    CrossrefPubMedGoogle Scholar
  • 55 Billinsky J, Glew RA, Cornish SM. , et al. No evidence of hypoglycemia or hypotension in older adults during 6 months of flax lignan supplementation in a randomized controlled trial: a safety evaluation. Pharm Biol 2013; 51 (06) 778-782
    CrossrefPubMedGoogle Scholar
  • 56 Di Y, Jones J, Mansell K. , et al. Influence of Flaxseed Lignan Supplementation to Older Adults on Biochemical and Functional Outcome Measures of Inflammation. J Am Coll Nutr 2017; 36 (08) 646-653
    CrossrefPubMedGoogle Scholar
  • 57 Park JB, Velasquez MT. Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. Fitoterapia 2012; 83 (05) 941-946
    CrossrefPubMedGoogle Scholar
  • 58 Canadian Grain Commission. 2007. Quality of western Canadian flaxseed. Available at: http://www.grainscanada.gc.ca/flax-lin/harvest-recolte/2007/flax-2007-eng.pdf . Accessed August 2008
    PubMedGoogle Scholar
  • 59 Udenigwe CC, Adebiyi AP, Doyen A, Li H, Bazinet L, Aluko RE. Low molecular weight flaxseed protein-derived arginine-containing peptides reduced blood pressure of spontaneously hypertensive rats faster than amino acid form of arginine and native flaxseed protein. Food Chem 2012; 132 (01) 468-475
    CrossrefPubMedGoogle Scholar
  • 60 Doyen A, Udenigwe CC, Mitchell PL, Marette A, Aluko RE, Bazinet L. Anti-diabetic and antihypertensive activities of two flaxseed protein hydrolysate fractions revealed following their simultaneous separation by electrodialysis with ultrafiltration membranes. Food Chem 2014; 145: 66-76
    CrossrefPubMedGoogle Scholar
  • 61 Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM. Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. Adv Nutr 2015; 6 (05) 513-540
    CrossrefPubMedGoogle Scholar
  • 62 Udenigwe CC, Lin YS, Hou WC, Aluko RE. Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. J Funct Foods 2009; 1: 199-207
    CrossrefPubMedGoogle Scholar
  • 63 Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999; 99 (10) 1355-1362
    CrossrefPubMedGoogle Scholar
  • 64 Prasad K. Serum biochemical changes in rabbits on a regular diet with and without flax lignan complex following a high-cholesterol diet. Int J Angiol 2008; 17 (01) 27-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 65 Prasad K. Effect of chronic administration of lignan complex isolated from flaxseed on the hemopoietic system. Mol Cell Biochem 2005; 270 (1,2): 139-145
    CrossrefPubMedGoogle Scholar